Thielke D - Search Results

1

Prototype of an evidence-based tool to aid individualized treatment for type 2 diabetes.

Buse JB, Holst I, Knop FK, Kvist K, Thielke D, Pratley R. Buse JB, et al. Among authors: thielke d. Diabetes Obes Metab. 2021 Jul;23(7):1666-1671. doi: 10.1111/dom.14381. Epub 2021 May 4. Diabetes Obes Metab. 2021. PMID: 33764641 Free PMC article.

2

Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial.

Zinman B, Bhosekar V, Busch R, Holst I, Ludvik B, Thielke D, Thrasher J, Woo V, Philis-Tsimikas A. Zinman B, et al. Among authors: thielke d. Lancet Diabetes Endocrinol. 2019 May;7(5):356-367. doi: 10.1016/S2213-8587(19)30066-X. Epub 2019 Mar 1. Lancet Diabetes Endocrinol. 2019. PMID: 30833170 Clinical Trial.

3

Impact on HbA1c and body weight of switching from other GLP-1 receptor agonists to semaglutide: A model-based approach.

Overgaard RV, Lindberg SØ, Thielke D. Overgaard RV, et al. Among authors: thielke d. Diabetes Obes Metab. 2019 Jan;21(1):43-51. doi: 10.1111/dom.13479. Epub 2018 Aug 23. Diabetes Obes Metab. 2019. PMID: 30047216 Free PMC article. Clinical Trial.

4

Days absent from work as a result of complications associated with type 2 diabetes: Evidence from 20 years of linked national registry data in Sweden.

Persson S, Johansen P, Andersson E, Lindgren P, Thielke D, Thorsted BL, Jendle J, Steen Carlsson K. Persson S, et al. Among authors: thielke d. Diabetes Obes Metab. 2020 Sep;22(9):1586-1597. doi: 10.1111/dom.14070. Epub 2020 May 22. Diabetes Obes Metab. 2020. PMID: 32329136

5

Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial.

Lingvay I, Catarig AM, Frias JP, Kumar H, Lausvig NL, le Roux CW, Thielke D, Viljoen A, McCrimmon RJ. Lingvay I, et al. Among authors: thielke d. Lancet Diabetes Endocrinol. 2019 Nov;7(11):834-844. doi: 10.1016/S2213-8587(19)30311-0. Epub 2019 Sep 17. Lancet Diabetes Endocrinol. 2019. PMID: 31540867 Clinical Trial.

6

Effects of once-weekly semaglutide vs once-daily canagliflozin on body composition in type 2 diabetes: a substudy of the SUSTAIN 8 randomised controlled clinical trial.

McCrimmon RJ, Catarig AM, Frias JP, Lausvig NL, le Roux CW, Thielke D, Lingvay I. McCrimmon RJ, et al. Among authors: thielke d. Diabetologia. 2020 Mar;63(3):473-485. doi: 10.1007/s00125-019-05065-8. Epub 2020 Jan 2. Diabetologia. 2020. PMID: 31897524 Free PMC article. Clinical Trial.

7

Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden.

Andersson E, Persson S, Hallén N, Ericsson Å, Thielke D, Lindgren P, Steen Carlsson K, Jendle J. Andersson E, et al. Among authors: thielke d. Diabetologia. 2020 Dec;63(12):2582-2594. doi: 10.1007/s00125-020-05277-3. Epub 2020 Sep 24. Diabetologia. 2020. PMID: 32968866 Free PMC article.

8

[Cardiac myxoma--a rare cause of cerebral embolism].

Thielke D, Thyssen JP, Sejersen HM. Thielke D, et al. Ugeskr Laeger. 2008 Aug 11;170(33):2460. Ugeskr Laeger. 2008. PMID: 18761832 Danish.

9

[Outpatient treatment of deep-vein thrombosis].

Thyssen JP, Thielke D, Ørnstrup ML, Sejersen HM. Thyssen JP, et al. Among authors: thielke d. Ugeskr Laeger. 2007 Jan 8;169(2):112-5. Ugeskr Laeger. 2007. PMID: 17227655 Danish.

10

[Orphan drugs--medications for patients with rare diseases].

Thielke D, Thyssen JP, Hansen BJ. Thielke D, et al. Ugeskr Laeger. 2006 Jun 5;168(23):2236-8. Ugeskr Laeger. 2006. PMID: 16768975 Danish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters